This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;21(8):1348-56.
doi: 10.3201/eid2108.140196.

Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands

Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands

Stephan P Keijmel et al. Emerg Infect Dis. 2015 Aug.

Abstract

Differentiating acute Q fever from infections caused by other pathogens is essential. We conducted a retrospective case-control study to evaluate differences in clinical signs, symptoms, and outcomes for 82 patients with acute Q fever and 52 control patients who had pneumonia, fever and lower respiratory tract symptoms, or fever and hepatitis, but had negative serologic results for Q fever. Patients with acute Q fever were younger and had higher C-reactive protein levels but lower leukocyte counts. However, a large overlap was found. In patients with an indication for prophylaxis, chronic Q fever did not develop after patients received prophylaxis but did develop in 50% of patients who did not receive prophylaxis. Differentiating acute Q fever from other respiratory infections, fever, or hepatitis is not possible without serologic testing or PCR. If risk factors for chronic Q fever are present, prophylactic treatment is advised.

Keywords: Coxiella burnetii; Q fever; acute Q fever; bacteria; case–control study; chronic Q fever; clinical practice; hospital; prophylactic treatment; prophylaxis; the Netherlands.

PubMed Disclaimer

References

    1. Delsing CE, Kullberg BJ, Bleeker-Rovers CP. Q fever in the Netherlands from 2007 to 2010. Neth J Med. 2010;68:382–7 . - PubMed
    1. Tilburg JJ, Rossen JW, van Hannen EJ, Melchers WJ, Hermans MH, van de Bovenkamp J, et al. Genotypic diversity of Coxiella burnetii in the 2007–2010 Q fever outbreak episodes in The Netherlands. J Clin Microbiol. 2012;50:1076–8 . 10.1128/JCM.05497-11 - DOI - PMC - PubMed
    1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999;12:518–53 . - PMC - PubMed
    1. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998;36:1823–34 . - PMC - PubMed
    1. Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis. 2005;5:219–26. 10.1016/S1473-3099(05)70052-9 - DOI - PubMed
Cite

AltStyle によって変換されたページ (->オリジナル) /